{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:11:43Z","timestamp":1791663103866,"version":"4.3.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/1479-5876-2-6","type":"journal-article","created":{"date-parts":[[2004,3,20]],"date-time":"2004-03-20T07:21:45Z","timestamp":1079767305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":99,"title":["Human primary osteoclasts: in vitro generation and applications as pharmacological and clinical assay"],"prefix":"10.1186","volume":"2","author":[{"given":"Mira","family":"Susa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngoc-Hong","family":"Luong-Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cappellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Zamurovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Gamse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,3,16]]},"reference":[{"key":"20_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","volume":"93","author":"DL Lacey","year":"1998","unstructured":"Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero R, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ: Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell. 1998, 93: 165-176.","journal-title":"Cell"},{"key":"20_CR2","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1006\/bbrc.1998.8586","volume":"246","author":"K Matsuzaki","year":"1998","unstructured":"Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T: Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun. 1998, 246: 199-204. 10.1006\/bbrc.1998.8586.","journal-title":"Biochem Biophys Res Commun"},{"key":"20_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/(SICI)1097-4644(19990201)72:2<251::AID-JCB9>3.0.CO;2-W","volume":"72","author":"V Shalhoub","year":"1999","unstructured":"Shalhoub V, Faust J, Boyle WJ, Dunstan CR, Kelley M, Kaufman S, Scully S, Van G, Lacey DL: Osteoprotegerin and osteoprotegerin ligand effects on osteoclast formation from human peripheral blood mononuclear cell precursors. J Cell Biochem. 1999, 72: 251-261. 10.1002\/(SICI)1097-4644(19990201)72:2<251::AID-JCB9>3.3.CO;2-N.","journal-title":"J Cell Biochem"},{"key":"20_CR4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1097-4652(199804)175:1<99::AID-JCP11>3.0.CO;2-J","volume":"175","author":"U Sarma","year":"1998","unstructured":"Sarma U, Edwards M, Motoyoshi K, Flanagan AM: Inhibition of bone resorption by 17beta-estradiol in human bone marrow cultures. J Cell Physiol. 1998, 175: 99-108. 10.1002\/(SICI)1097-4652(199804)175:1<99::AID-JCP11>3.3.CO;2-L.","journal-title":"J Cell Physiol"},{"key":"20_CR5","doi-asserted-by":"publisher","first-page":"3736","DOI":"10.1210\/en.140.8.3736","volume":"140","author":"G Mbalaviele","year":"1999","unstructured":"Mbalaviele G, Jaiswal N, Meng A, Cheng L, Van Den Bos C, Thiede M: Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology. 1999, 140: 3736-3743. 10.1210\/en.140.8.3736.","journal-title":"Endocrinology"},{"key":"20_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/cs0990133","volume":"99","author":"GC Nicholson","year":"2000","unstructured":"Nicholson GC, Malakellis M, Collier FM, Cameron PU, Holloway WR, Gough TJ, Gregorio-King C, Kirkland MA, Myers DE: Induction of osteoclasts from CD14-positive human peripheral blood mononuclear cells by receptor activator of nuclear factor kappaB ligand (RANKL). Clin Sci (Lond). 2000, 99: 133-140. 10.1042\/CS19990355.","journal-title":"Clin Sci (Lond)"},{"key":"20_CR7","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/(SICI)1097-4644(20000801)78:2<318::AID-JCB13>3.0.CO;2-N","volume":"78","author":"MN Weitzmann","year":"2000","unstructured":"Weitzmann MN, Cenci S, Haug J, Brown C, DiPersio J, Pacifici R: B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. J Cell Biochem. 2000, 78: 318-324. 10.1002\/(SICI)1097-4644(20000801)78:2<318::AID-JCB13>3.0.CO;2-N.","journal-title":"J Cell Biochem"},{"key":"20_CR8","first-page":"s265","volume":"15","author":"J Scopes","year":"2000","unstructured":"Scopes J, Massey HM, Flanagan AM: TGFb enhances human osteoclast formation and bone resorption at the expense of macrophages. J Bone Miner Res. 2000, 15: s265-","journal-title":"J Bone Miner Res"},{"key":"20_CR9","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1359\/jbmr.1999.14.9.1562","volume":"14","author":"IE James","year":"1999","unstructured":"James IE, Lark MW, Zembryki D, Lee-Rykaczewski EV, Hwang SM, Tomaszek TA, Belfiore P, Gowen M: Development and characterization of a human in vitro resorption assay: demonstration of utility using novel antiresorptive agents. J Bone Miner Res. 1999, 14: 1562-1569.","journal-title":"J Bone Miner Res"},{"key":"20_CR10","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1210\/en.139.7.3157","volume":"139","author":"CS Lader","year":"1998","unstructured":"Lader CS, Flanagan AM: Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro. Endocrinology. 1998, 139: 3157-3164. 10.1210\/en.139.7.3157.","journal-title":"Endocrinology"},{"key":"20_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/S8756-3282(01)00432-X","volume":"28","author":"HM Massey","year":"2001","unstructured":"Massey HM, Scopes J, Horton MA, Flanagan AM: Transforming growth factor-beta1 (TGF-beta) stimulates the osteoclast-forming potential of peripheral blood hematopoietic precursors in a lymphocyte-rich microenvironment. Bone. 2001, 28: 577-582. 10.1016\/S8756-3282(01)00432-X.","journal-title":"Bone"},{"key":"20_CR12","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1359\/jbmr.1998.13.11.1730","volume":"13","author":"JP David","year":"1998","unstructured":"David JP, Neff L, Chen Y, Rincon M, Horne WC, Baron R: A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation. J Bone Miner Res. 1998, 13: 1730-1738.","journal-title":"J Bone Miner Res"},{"key":"20_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S8756-3282(01)00685-8","volume":"30","author":"A Taranta","year":"2002","unstructured":"Taranta A, Brama M, Teti A, De Luca V, Scandurra R, Spera G, Agnusdei D, Termine JD, Migliaccio S: The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro. Bone. 2002, 30: 368-376. 10.1016\/S8756-3282(01)00685-8.","journal-title":"Bone"},{"key":"20_CR14","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.1210\/endo.142.12.8533","volume":"142","author":"V Parikka","year":"2001","unstructured":"Parikka V, Lehenkari P, Sassi ML, Halleen J, Risteli J, Harkonen P, Vaananen HK: Estrogen reduces the depth of resorption pits by disturbing the organic bone matrix degradation activity of mature osteoclasts. Endocrinology. 2001, 142: 5371-5378. 10.1210\/en.142.12.5371.","journal-title":"Endocrinology"},{"key":"20_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1043-4666(03)00179-0","volume":"23","author":"MS Kung Sutherland","year":"0263","unstructured":"Kung Sutherland MS, Lipps SG, Patnaik N, Gayo-Fung LM, Khammungkune S, Xie W, Brady HA, Barbosa MS, Anderson DW, Stein B: SP50 a novel SERM, blocks osteoclastogenesis in a human bone cell model: role of IL-6 and GM-CSF. Cytokine. 0263, 23: 1-14. 10.1016\/S1043-4666(03)00179-0.","journal-title":"Cytokine"},{"key":"20_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1053\/sonc.2002.37421","volume":"29","author":"JR Green","year":"2002","unstructured":"Green JR: Preclinical pharmacology of zoledronic acid. Semin Oncol. 2002, 29: 3-11. 10.1053\/sonc.2002.37421.","journal-title":"Semin Oncol"},{"key":"20_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11926-003-0085-6","volume":"5","author":"AA Reszka","year":"2003","unstructured":"Reszka AA, Rodan GA: Bisphosphonate mechanism of action. Curr Rheumatol Rep. 2003, 5: 65-74.","journal-title":"Curr Rheumatol Rep"},{"key":"20_CR18","doi-asserted-by":"publisher","first-page":"7829","DOI":"10.1073\/pnas.130200197","volume":"97","author":"NK Shevde","year":"2000","unstructured":"Shevde NK, Bendixen AC, Dienger KM, Pike JW: Estrogens suppress RANK ligand-induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci U S A. 2000, 97: 7829-7834. 10.1073\/pnas.130200197.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1210\/er.2001-9002","volume":"23","author":"A Cranney","year":"2002","unstructured":"Cranney A, Guyatt G, Griffith L, Wells G, Tugwell P, Rosen C, Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group: Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr Rev. 2002, 23: 570-578. 10.1210\/er.2001-9002.","journal-title":"Endocr Rev"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1479-5876-2-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T16:29:07Z","timestamp":1726244947000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/1479-5876-2-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3,16]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2004,12]]}},"alternative-id":["20"],"URL":"https:\/\/doi.org\/10.1186\/1479-5876-2-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3,16]]},"assertion":[{"value":"2 February 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2004","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2004","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}